TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says September 24, 1999
TCL Archive In Brief: NCI Future Budget Planning Now In Open; One Or Two comp Centers In 12-18 Months May 28, 1976
TCL Archive Colorectal Cancer Gene Carriers Seek Screening More Frequently, Study Finds November 29, 2002
